NYU Langone Health May 7 2026 A tool developed by the American Heart Association (AHA), proven to accurately predict heart disease risk for Americans, can be applied to the global population, a new study led by NYU Langone Health shows. Accurate identification of those at high cardiovascular disease (CVD) risk enables targeted use of preventive therapies, such as lipid-lowering medications and intensive blood pressure targets, and can move patients to quit smoking, eat better, and exercise, the